Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

12277 from 12311 pages
No results were found for the filter!
PD-1/PD-L1-IN-16
PD-1/PD-L1-IN-16

Item number: TGM-T63948-100mg

Description: PD-1/PD-L1-IN-16, a potent inhibitor of PD-1/PD-L1 (IC50: 53.2 nM), has demonstrated research potential for tumor immunotherapy. Target: Others
MW: 558.63 D
From 1,440.00€ *
Review
ZINC000104379474
ZINC000104379474

Item number: TGM-T63951-100mg

Description: ZINC000104379474 is a compound targeting SARS-CoV-2 endoribonuclease. Target: Others
MW: 559.57 D
From 1,440.00€ *
Review
GRPR antagonist-2
GRPR antagonist-2

Item number: TGM-T63952-100mg

Description: GRPR antagonist-2 is a potent antagonist of the gastrin-releasing peptide receptor (GRPR) and exhibits anticancer effects with cytotoxicity to HGC-27 cells (IC50: 0.77 µM) and Pan02 cells (IC50: 2.5 µM). Target: Others
MW: 559.58 D
From 1,440.00€ *
Review
OP-5244 sodium
OP-5244 sodium

Item number: TGM-T63956-10mg

Description: OP-5244 sodium is a potent, orally active inhibitor of CD73 (IC50: 0.25 nM). OP-5244 sodium has shown potential for cancer research by blocking adenosine production and thereby reversing immunosuppression. Target: Others
MW: 559.87 D
From 1,099.00€ *
Review
HIV-1 inhibitor-14
HIV-1 inhibitor-14

Item number: TGM-T63963-100mg

Description: HIV-1 inhibitor-14 is a potent, broad-spectrum inhibitor of HIV-1 non-nucleoside reverse transcriptase (RT) (IC50=0.14 µM for HIV-1 RT). HIV-1 inhibitor-14 inhibits both wild-type and drug-resistant HIV-1 strains (EC50: 5.79-28.3 nM). Target: Others
MW: 560.67 D
From 1,440.00€ *
Review
AZ14145845
AZ14145845

Item number: TGM-T63968-100mg

Description: AZ14145845 is an in vivo potent and highly selective type I1/2 Mer/Axl bispecific kinase inhibitor. Target: Others
MW: 561.68 D
From 1,108.00€ *
Review
AZ13824374
AZ13824374

Item number: TGM-T63976-100mg

Description: AZ13824374 is a potent and selective ATAD2 inhibitor with anti-proliferative effects in breast cancer. pIC50 values for AZ13824374 against ATAD2 in the ATAD2 FRET and ATAD2 NanoBRET assays were 8.2 and 6.2, respectively. Target: Others
MW: 562.68 D
From 4,383.00€ *
Review
FAK-IN-2
FAK-IN-2

Item number: TGM-T63978-100mg

Description: FAK-IN-2 is a potent, orally active adherens spot kinase (FAK) inhibitor (IC50: 35 nM) that exhibits antitumour effects. FAK-IN-2 covalently inhibits FAK autophosphorylation in a dose-dependent manner and also inhibits tumour cell formation and migration and induces apoptosis. Target: Others
MW: 563.05 D
From 1,440.00€ *
Review
PF-3758309 dihydrochloride
PF-3758309 dihydrochloride

Item number: TGM-T63984-100mg

Description: PF-3758309 dihydrochloride is a potent, reversible, orally active, ATP-competitive PAK4 inhibitor with a Kd value of 2.7 nM and a Ki value of 18.7 nM. PF-3758309 dihydrochloride exhibits the expected cellular functions of a PAK4 inhibitor, with the ability to inhibit anchorage independent growth,...
MW: 563.55 D
From 1,440.00€ *
Review
BRD4/CK2-IN-1
BRD4/CK2-IN-1

Item number: TGM-T63991-100mg

Description: BRD4/CK2-IN-1 is the first potent, orally active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with inhibitory concentrations (IC50) of 180 nM for BRD4 and 230 nM for CK2. In triple-negative breast cancer (TNBC), BRD4/CK2-IN-1 induces apoptosis and...
MW: 564.03 D
From 1,412.00€ *
Review
DX3-234
DX3-234

Item number: TGM-T64004-100mg

Description: DX3-234 is an inhibitor of oxidative phosphorylation (OXPHOS). In a Pan02 homozygous model of pancreatic cancer, DX3-234 exhibits significant tumour suppressive activity. Target: Others
MW: 565.71 D
From 1,440.00€ *
Review
PDE4B-IN-3
PDE4B-IN-3

Item number: TGM-T64005-100mg

Description: PDE4B-IN-3 is a potent PDE4B inhibitor (IC50: 0.94 µM) with anti-inflammatory effects. Target: Others
MW: 565.75 D
From 1,412.00€ *
Review
12277 from 12311 pages